| Name | Title | Contact Details |
|---|
Meritech is the leader in automated hygiene technology and creator of CleanTech: the world`s only fully automated handwashing technology clinically proven to consistently remove more than 99.9% of harmful pathogens from hands in just 12 seconds. Meritech also offers a full line of footwear sanitization equipment, which when paired with CleanTech® provides a full cGMP employee hygiene protocol for production facilities. We help food manufacturers, clean room practitioners, healthcare and medical staff, food service providers, retailers, public spaces and entertainment facilities, cruise lines, and academic institutions achieve hygiene excellence with our innovative hygiene technology, solutions, and programs so that we together can save lives by preventing the spread of infection and harmful diseases. Our innovative technology and hygiene program solutions have been developed and refined over decades by an experienced team of sanitation, food safety, and healthcare experts. Their unique insights and experience have allowed us to craft solutions that are clinically proven to increase handwashing efficacy and compliance, are easily integrated into any facility, exceed regulatory and safety requirements, and make hygiene compliance monitoring and documentation effortless.
Supply King Inc is a Neptune, NJ-based company in the Manufacturing sector.
Aspen Hills Inc is a Garner, IA-based company in the Manufacturing sector.
Metallurgical Products Co Inc is a West Chester, PA-based company in the Manufacturing sector.
Digital Diagnostics is a pioneering AI diagnostics company on a mission to transform the quality, accessibility and affordability of healthcare. Founded and led by Dr. Michael Abramoff, an ophthalmologist, neuroscientist and computer engineer, Digital Diagnostics developed a patented biomarker-based approach to build autonomous algorithms that make clinical decisions without human intervention. Digital Diagnostics and its flagship product IDx-DR, an autonomous AI system FDA-authorized to diagnose diabetic retinopathy and diabetic macular edema, has proven that intelligent diagnostic platforms can be used safely, efficiently and equitably to improve patient outcomes. As it expands into other diagnostic capabilities, Digital Diagnostics has paved the way for automated diagnosis to become a new standard of care that will contribute significantly to democratizing healthcare.